Company Overview of Adlyfe Inc.
Adlyfe Inc., a biotechnology company, develops solutions for early detection of protein misfolding diseases. The company focuses on creating in vitro diagnostic and imaging tests for Alzheimer’s disease and other neurodegenerative diseases. It offers Pronucleon, a platform technology using custom-synthesized peptides that allow signal amplification to map the surface of rare proteins; and molecular biomarkers for Alzheimer’s disease. The company offers its products for Alzheimer’s disease, other misfolding protein diseases, and therapeutic potential markets. Adlyfe Inc. was founded in 2003 and is based in Rockville, Maryland.
9430 Key West Avenue
Rockville, MD 20850
Founded in 2003
Key Executives for Adlyfe Inc.
Adlyfe Inc. Key Developments
Similar Private Companies By Industry
|Kenna Technologies, Inc.||United States|
|Gem Pharmaceuticals, LLC||United States|
|Gantech International, Inc.||United States|
|Laser Isotope Enrichment Laboratory||United States|
|AureoGen Biosciences, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Adlyfe Inc., please visit www.adlyfe.com. Company data is provided by Capital IQ. Please use this form to report any data issues.